Parkinson’s Disease Therapeutic Market Size Projections : The global Parkinson’s disease therapeutic market is estimated to be valued at US$ 4,697.3 million in 2022 and is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).
The premium market research firm Coherent Market Insights has published a new market study titled “Parkinson’s Disease Therapeutic Market” Share, Size, Trends, Industry Analysis Report 2023 – 2030.” The report offers new perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace.
Parkinson’s disease is a neurological ailment that results in a movement dysfunction. Common symptoms include tremor, sluggishness, tight muscles, uneven gait, imbalance, and poor coordination. Some of the drugs used to treat Parkinson’s disease include levodopa, dopamine agonists, MAO-B inhibitors, and anticholinergics. The medication that is most frequently administered for Parkinson’s disease is levodopa, generally known as L-dopa. It helps to reduce symptoms including sluggish movements and tight and rigid body parts. Most individuals can maintain a high quality of life with medication, and other patients may benefit from surgery to reduce their symptoms. Patients with Parkinson’s disease also notice a decline in the neurotransmitter norepinephrine. The sympathetic nervous system needs this chemical to function properly. This system regulates a few autonomic functions of the body, such as breathing, heart rate, blood pressure, and digestion. Lack of norepinephrine contributes to several of the Parkinson’s disease symptoms that are not movement-related. Exercise significantly reduces the symptoms of Parkinson’s disease. Along with helping with speech impairments, eating and swallowing problems, and balance problems, physical therapy, occupational therapy, and speech-language therapy can also help with walking and balance problems.
Note – Updated Version 2023 is available
What’s New for 2023?
Global competitiveness and key competitor market share percentages
Strong/Active/Niche/Trivial market presence across multiple geographies
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
To carefully analyze and forecast the size of Parkinson’s Disease Therapeutic Market by value and volume.
To estimate the market shares of major segments of the Industry
To highlight the development of the Parkinson’s Disease Therapeutic Market in different parts of the world.
To analyze and study micro-markets in terms of their contributions, prospects, and individual growth trends.
To offer precise and useful details about factors affecting revenue growth over the forecast period.
To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Parkinson’s Disease Therapeutic market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.
Companies:Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline Plc., AbbVie Inc., Merck & Co., Inc., Zydus Cadila, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries Ltd., Cipla Inc., and Boehringer Ingelheim International GmbH.
SWOT Analysis of Global Parkinson’s Disease Therapeutic Market
In addition to market share analysis of companies, in-depth profile, product/service, and business overview, the study focuses on revenue analysis, as well as SWOT analysis, to better correlate market competitiveness.
▻ Defined your buyer persona ▻ Identified a persona group to engage ▻ Prepared research questions for your market research participants ▻ Lists of your primary competitors ▻ Summarized your findings
Purchasing the Parkinson’s Disease Therapeutic Market for the Following Reasons:
The study examines emerging market trends as well as the likelihood that various trends will impact expansion. The analysis also discusses the factors, challenges, and opportunities that will have a significant impact on the global Parkinson’s Disease Therapeutic industry. Technological tools and benchmarks that reflect the industry’s projected growth of the Parkinson’s Disease Therapeutic industry. The research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates.
What are the goals of the report?
⮞ The predicted market size for the Parkinson’s Disease Therapeutic Market Industry at the conclusion of the forecast period is shown in this market report. ⮞ The paper also analyses market sizes in the past and present. ⮞ The charts show the year-over-year growth (percent) and compound annual growth rate (CAGR) for the given projected period based on a variety of metrics. ⮞ The research contains a market overview, geographical breadth, segmentation, and financial performance of main competitors. ⮞ The research evaluates the current situation of the industry in North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa,as well as future growth opportunities. ⮞ The study examines the future period’s growth rate, market size, and market worth.
Some of the Key Questions Answered in this Report:
What will be the market size and the growth rate by the end of the forecast period?
What are the key Parkinson’s Disease Therapeutic Market trends impacting the growth of the market?
What are the potential growth opportunities and threats faced by the leading competitors in the market?
What are the key outcomes of Porter’s five forces analysis and the SWOT analysis of the key players functioning in the global Parkinson’s Disease Therapeutic Market?
This report gives all the information regarding industry Overview, analysis and revenue of this market.
What are the market opportunities and threats faced by the vendors in the global Parkinson’s Disease Therapeutic Market?
• Key Emerging Trends • Key Developments Mergers and Acquisition • New Product Launches and Collaboration • Partnership and Joint Venture • Latest Technological Advancements • Insights on Regulatory Scenario • Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Parkinson’s Disease Therapeutic Market
• Supply Chain Challenges • Steps taken by Government/Companies to overcome this impact • Potential opportunities due to COVID-19 outbreak
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States Email: [email protected] United States of America: +1-206-701-6702 United Kingdom: +44-020-8133-4027 Japan: +050-5539-1737 India: +91-848-285-0837
Breathing+ by Breathing Labs has passed peer review in a randomized controlled clinical trial that was recently published in SCI Q2 journal Pediatric Pulmonology. Research done by @bezmialem Full text is available in a link here: https://www.breathinglabs.com/clinical-trials/research-breathing-labs-and-nintendo-clinical-trial-is-published-in-journal-pediatric-pulmonology-sci-q2-impact-factor-3/?fbclid=IwAR2wNhSgurdbrrf3gzOOkHthgiWfXJ1x8RWvnMhkSo6fi33QPZEGzxzd6jM
BREAKING: @breathinglabs and @Nintendo clinical trial is published in journal Pediatric Pulmonology (SCI Q2, Impact Factor > 3), full text: https://breathinglabs.com/Nintendo%20&%20Breathing%20Labs%202022 #telemedicine #telehealth #mhealth
Clinical mouthpieces 10pcs packages are now available at 45€/50USD (shipping cost not included). Learn more: https://www.breathinglabs.com/latest-news/announcement-breathing-mouthpieces-for-clinical-and-professional-use-are-now-available/
BREATHING VR: Lately we are sourcing this VR headset for use in Breathing VR application. It allows easiest installation of both breathing+ headset cable, and USB charging cables, which is essential in professional use: https://www.banggood.com/VR-SHINECON-G5-VR-Glasses-3D-Virtual-Reality-Glasses-VR-Headset-For-iPhone-XS-11Pro-Mi10-p-1679808.html?rmmds=myorder&cur_warehouse=CN
Update: Each purchase of Breathing+ will now include three machine washable mouthpieces. Previous buyers will be supplied with those by their country representatives but will have to cover shipping costs. Please be patient while we arrange distribution. https://www.breathinglabs.com/latest-news/announcement-breathing-mouthpieces-for-clinical-and-professional-use-are-now-available/
Update: We moved servers + relocated all our games to our servers, please be patient while google reviews all that (showing unsafe website atm). Use duckduckgo or non-chromium browsers to reach our pages in the meantime. Everything ok + new product addons coming out in a month!
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys and tens stimulation + in November we will be signing up new erasmus traineeships, research projects, bilateral, FP(eu), and asia-pacific ->[email protected]
Notice to b2b partners: we are running late with some minor upgrade-> briefly running out of stock -> retail and b2b sale is closed until early october. To get a list of partners with stock to sell contact us at [email protected] Thanks, we'll go strong again in winter 💪